Skip to content

Advertisement

  • Invited speaker presentation
  • Open Access

Gene therapy to cure HIV? Prospects and realities

  • 1
Retrovirology20129 (Suppl 1) :I3

https://doi.org/10.1186/1742-4690-9-S1-I3

  • Published:

Keywords

  • Gene Therapy
  • Hematopoietic Stem Cell Transplantation
  • Peripheral Blood Cell
  • Allogeneic Transplantation
  • Haematopoietic Stem Cell

Introduction

HIV-1 can persist in a latent form in resting memory CD4+ cells and macrophages carrying an integrated copy of the HIV genome. Because of the presence of these stable reservoir cells, eradication by antiretroviral therapy is unlikely and in order to achieve eradication, alternative treatment options are required.

Materials and methods

Recently, we have described a successful hematopoietic stem cell transplantation in an HIV-1 infected patient transferring donor derived cells with a natural resistance against HIV infection. These haematopoietic stem cells engrafted, proliferated and differentiated into mature myeloid and lymphoid cells.

Results

At present the patient is more than five years after allogeneic transplantation without requirement of any antiretroviral treatment. Analyzing peripheral blood cells and different tissue samples including gut, liver, and brain, no viral load or proviral DNA could be detected.

Conclusions

There is a degree of optimism that gene therapy in combination with SCT can improve HIV-1 treatment. After nearly 30 years of research and progress HIV infection has become a chronic disease in developed countries. However, the evolution of this infectious agent, due to its rapid mutation, is quite unpredictable. Therefore, strategies to eliminate the virus from the body to achieve cure are desirable. Currently, HIV-targeted gene therapy appears to have great potential as an effective strategy that may eliminate or reduce the need for antiretroviral therapy and achieve elimination of the viral reservoir.

Authors’ Affiliations

(1)
Heidelberg University, Württemberg, Germany

Copyright

© Hütter; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement